<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230726058936N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-29</date_registration>
      <primary_sponsor>Ahvaz University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Cognitive Behavioral Counseling on Anxiety Thoughts in Pregnant Women with a History of Fetal Abnormality</public_title>
      <acronym></acronym>
      <scientific_title>The effect of counseling based on cognitive behavioral therapy on anxiety thoughts of pregnant women with a history of fetal abnormalities</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>46</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71727</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Other, Purpose: Education/Guidance, Other design features: The questionnaire completed at the beginning of the study will be as a pretest of both intervention and control groups, and then the intervention group will receive cognitive-behavioral therapy in the form of 8 sessions of 90 minutes, once a week, and the control group will only receive routine prenatal care, Randomization description: . The method of assigning intervention to the subjects is randomized, using random permutation blocks with block size 4 (using the table related to random permutations) and with a ratio of 1:1. The randomization list is prepared by a statistical expert. Codes assigned to qualified individuals by an outside person who does not know the research objectives will be plThey will not know who is in the group, Blinding description: This way, the researcher and participants will be unaware of who is in what group until the study begins.</study_design>
      <phase>N/A</phase>
      <hc_freetext>anxiety thoughts of pregnant women with a history of fetal abnormalities.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention in this study starts from the age of 18 to 20 weeks of pregnancy (that is, after the results of fetal abnormality screening and ultrasound) and the end of the intervention is after 8 weeks of counseling session. The intervention group will receive cognitive-behavioral therapy in the form of 8 sessions of 90 minutes, once a week. Session plan: The first session: introducing the members to each other, the rules and structure of the group, explaining the purpose of the study to the participants, emphasizing Confidentiality of answers, treatment contract, description of how to complete the questionnaire, familiarization with the problem of anxiety thoughts caused by fetal abnormality, description of cognitive-behavioral therapy and the beginning of the second session training: cognitive skills training, review of the topics of the first session, relaxation training, skill training Imagination, presentation of the task of the third session: getting to know the negative thoughts and beliefs that cause negative feelings towards the current pregnancy with regard to the experience of abnormality in the previous pregnancy, reviewing the previous session and checking the completion of the task, describing different types of maladaptive cognitions, recognizing Inconsistent thoughts and self-talks, description of emotions associated with inconsistent cognition, presentation of the assignment of the fourth session: explanation of the effect of psychological factors on the outcome of the current pregnancy, review of the previous session and review of the assignment, training of psychological factors (founding factors, revealing factors, maintaining factors) ), presentation of the task of the fifth session: cognitive restructuring, review of the previous session and review of homework, cognitive restructuring and change of negative attitude towards the current pregnancy, presentation of the task of the sixth session: teaching to correct anxious thoughts, review of the previous session and review of homework, review Anxious thoughts and challenging their validity, presentation of the assignment of the seventh session: training to replace positive thoughts instead of anxious thoughts, review of the previous session and review of the assignment of the eighth session: training of communication skills and problem solving, overview, implementation of the post-test. Intervention 2: Control group: El cuestionario de información demográfica y el cuestionario de pensamientos de ansiedad serán aplicados a gestantes con antecedentes de anomalías fetales con edad gestacional de 18-20 semanas que remitan a centros de salud que reúnan las condiciones para ingresar al estudio, y el grupo control recibirá únicamente los cuidados habituales del embarazo.Tras finalizar el estudio, el grupo control recibirá el tratamiento basado en el asesoramiento cognitivo-conductual en forma de reunión presencial junto con un CD con el material enseñado al grupo intervención.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zeinab Davoodi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Davood Davoodi Alley, Takhti Sq., Emam Ave.</address>
        <city>Izeh</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6391753611</zip>
        <telephone>+98 61 4365 1444</telephone>
        <email>Jan_jani36@yahoo.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zeinab Davoudi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Street, Daud Davodi Street</address>
        <city>Izeh</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6391753611</zip>
        <telephone>+98 61 4365 1444</telephone>
        <email>jan_jani36@yahoo.com</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Minimum primary education
2. Age 18 to 40 years
3. Gestational age 18 to 20 weeks
4. History of fetal abnormality in previous pregnancy
5. Score one standard deviation above the mean in Wells anxiety thoughts questionnaire</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>1. Chronic diseases such as heart disease, high blood pressure, diabetes
2. Mental illness in recent years and taking psychotropic drugs
3. Drug and Cigarette Addiction
4. Pregnancy complications such as preeclampsia, bleeding
5. Absence of more than two sessions in therapy sessions
6. Attending counseling sessions during the study or three months before the study
7. Dealing with stressful events such as separation crisis or death of first-degree relatives</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention in this study starts from the age of 18 to 20 weeks of pregnancy (that is, after the results of fetal abnormality screening and ultrasound) and the end of the intervention is after 8 weeks of counseling session. The intervention group will receive cognitive-behavioral therapy in the form of 8 sessions of 90 minutes, once a week. Session plan: The first session: introducing the members to each other, the rules and structure of the group, explaining the purpose of the study to the participants, emphasizing Confidentiality of answers, treatment contract, description of how to complete the questionnaire, familiarization with the problem of anxiety thoughts caused by fetal abnormality, description of cognitive-behavioral therapy and the beginning of the second session training: cognitive skills training, review of the topics of the first session, relaxation training, skill training Imagination, presentation of the task of the third session: getting to know the negative thoughts and beliefs that cause negative feelings towards the current pregnancy with regard to the experience of abnormality in the previous pregnancy, reviewing the previous session and checking the completion of the task, describing different types of maladaptive cognitions, recognizing Inconsistent thoughts and self-talks, description of emotions associated with inconsistent cognition, presentation of the assignment of the fourth session: explanation of the effect of psychological factors on the outcome of the current pregnancy, review of the previous session and review of the assignment, training of psychological factors (founding factors, revealing factors, maintaining factors) ), presentation of the task of the fifth session: cognitive restructuring, review of the previous session and review of homework, cognitive restructuring and change of negative attitude towards the current pregnancy, presentation of the task of the sixth session: teaching to correct anxious thoughts, review of the previous session and review of homework, review Anxious thoughts and challenging their validity, presentation of the assignment of the seventh session: training to replace positive thoughts instead of anxious thoughts, review of the previous session and review of the assignment of the eighth session: training of communication skills and problem solving, overview, implementation of the post-test</i_keyword>
      <i_keyword>Control group: El cuestionario de información demográfica y el cuestionario de pensamientos de ansiedad serán aplicados a gestantes con antecedentes de anomalías fetales con edad gestacional de 18-20 semanas que remitan a centros de salud que reúnan las condiciones para ingresar al estudio, y el grupo control recibirá únicamente los cuidados habituales del embarazo.Tras finalizar el estudio, el grupo control recibirá el tratamiento basado en el asesoramiento cognitivo-conductual en forma de reunión presencial junto con un CD con el material enseñado al grupo intervención.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxious thoughts score in the Wells Anxiety Thoughts Questionnaire. Timepoint: Before the intervention began.At the beginning of the study (before the start of the intervention) and at the end of the intervention (8 weeks after the start of the intervention) and one month after the end of the intervention with Wells Anxiety Thought Questionnaire. Method of measurement: Wells Anxiety Thought Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ahvaz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-07-23</approval_date>
        <contact_name>Ethics Committee of Ahvaz Jundishapur University of Medical Sciences</contact_name>
        <contact_address>Davood Davoodi Alley, Takhti Sq., Emam Ave. izeh Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
